Achieving dynamic efficiency in pharmaceutical innovation : identifying the optimal share of value and payments required
Year of publication: |
2024
|
---|---|
Authors: | Woods, Beth ; Lomas, James ; Sculpher, Mark ; Weatherly, Helen ; Claxton, Karl |
Published in: |
Health economics. - New York, NY : Wiley, ISSN 1099-1050, ZDB-ID 1483261-6. - Vol. 33.2024, 4, p. 804-819
|
Subject: | analysis of health care markets | dynamic efficiency | government policy | pharmaceutical pricing | public health | regulation | static efficiency | Effizienz | Efficiency | Arzneimittel | Pharmaceuticals | Gesundheitspolitik | Health policy | Pharmaindustrie | Pharmaceutical industry | Gesundheitswesen | Health care system | Innovation | Gesundheitskosten | Health care costs | Theorie | Theory | Regulierung | Regulation |
-
Towse, Adrian, (2015)
-
Late-stage pharmaceutical R&D and pricing policies under two-stage regulation
Jobjörnsson, Sebastian, (2016)
-
Has pharmaceutical innovation reduced the average cost of U.S. health care episodes?
Lichtenberg, Frank R., (2024)
- More ...
-
Woods, Beth, (2021)
-
Country-level cost-effectiveness thresholds : initial estimates and the need for further research
Woods, Beth, (2015)
-
Country-level cost-effectiveness thresholds: initial estimates and the need for further research
Woods, Beth, (2015)
- More ...